Reveles_Logo_icon.png

BRINGING HOPE CLOSER TO HOME

REVELES      
CLINICAL TRIAL
SUPPORT & SERVICES

Reveles Clinical Services is a purposeful, technology-enabled clinical research solutions company. Reveles’ mission is Bringing Hope Closer To Home ™. Our vision is to become the preeminent provider and collaborator of clinical research solutions that accelerates the clinical development process and provides hope to patients with rare/complex diseases. 

WHY
REVELES

Reveles has a commitment to expanding the population of people who are able to participate in clinical trials by removing the barriers that have long existed — particularly for minorities and underserved communities. We believe this important work will benefit patients, industry sponsors, and clinical researchers alike. 

01

02

03

Increasing Awareness

In working to reach ethnic minorities and underserved communities, Reveles is helping to expand knowledge of clinical trials to a broader, more diverse population.

Expanded Access

By providing researchers and prospective trial participants with more ways to connect, Reveles is bringing hope to more patients and families. Sponsors in turn gain access to a more diverse population that could bring greater validity to their trial results.

Fostering Trust 

By leveraging relationships with organizations that engage with ethnic minorities and the underserved, Reveles is working to foster trust and engagement in communities that are largely new to clinical research.

 
 

70%

70% of potential participants live more than 2 hours away from their nearest study center which limits recruitment and retention. (1)

80%

Out of 40,000 clinical trials recruiting in the US, 80% were delayed due to recruitment challenges. (2)

85%

85% of clinical trials fail to retain enough patients. (3) 

30%

Across all clinical trials the average drop-out rate is 30%, when more than 12,000 people. (4)

75%

More than 75% responded that collecting all data on their own at home or having nurses come to their home for all study visits were appealing choices (3)

WHY DCT
(DECENTRALIZED CLINICAL TRIALS)

DCT
ADVANCING DIVERSITY 

Father and Son Baking

Reveles is expanding access to clinical research by combining local healthcare providers and digital health technologies. DCT's functions accelerate the drug development process through enhanced recruitment and retention, which result in faster completion times, increasing the speed of delivery of therapies to patients and creating efficiencies across clinical research processes.

DCT ADVANTAGES

Sites that have conducted at least one DCT reported multiple benefits, including decreased workload and less time  spent on administrative tasks. Patients expressed more interest in clinical trials due to less travel and increased flexibility, and having access to  study data anywhere at any time. 

Faster Trial

 Recruitment

Improved Trial Participant Retention

Home Administration and Direct-to-Patient Supply

Increased Participant Diversity

Improved Data Quality

Improved Patient Experience

PARTNERING TOGETHER
TO
 BRING HOPE CLOSER  TO HOME

Whether a Site, CRO or Sponsor, Reveles is more than prepared to be  your collaborative partner within the clinical research ecosystem. Let's work together to start Bringing Hope Closer to Home . 

WE HAVE A FULLY DEDICATED DCT FACILITY

Our success depends on the highly-specialized, multi-disciplinary team with deep industry expertise discovering new drugs and innovating for the next generation. A fully-dedicated DCT facility and culture ensure they have a platform to do their best work.

IMG_7924.jpg

CURRENT STRATEGIC PARTNERSHIPS

Radyus Logo Final_Green-Orange.png
Acclinate-logo-color.png
global genes.png
etect%20rx_edited_edited.png
rare%20patient%20voice_edited_edited.png
tech med_edited.png
TN Color logo with background.png

CONTACT
A REVELATOR

To learn more about how we are Bringing Hope Closer to Home, please fill in your contact details.

Thanks for submitting!